TOP TIERMARKET NEWSWIRE
SEC Form 4 history

OCULAR THERAPEUTIX I (OCUL) insider trades

OCULAR THERAPEUTIX I (OCUL) insider trading activity (SEC Form 4). Over the trailing 90 days, OCUL insiders filed 0 purchases totalling $0 and 5 sales totalling $360K — net SELLING of $360K. Most recent filing: Jun 5, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
5
$360K
Net (90d)
-$360K
net selling
Most recent
Jun 5, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Jun 5, 2026Waheed NadiaChief Medical OfficerS Sale—$8.27$123Kfiling
May 28, 2026Kaiser PeterChief Development OfficerS Sale—$8.20$24Kfiling
May 28, 2026Dugel PravinSee RemarksS Sale—$8.20$173Kfiling
May 28, 2026Nayak SanjayChief Strategy OfficerS Sale—$8.20$15Kfiling
May 28, 2026Heier Jeffrey S.Chief Scientific OfficerS Sale—$8.20$25Kfiling